Insider Trading (SEC Form 4)


Insiders are officers, directors, or significant investors. This page shows recent insider transactions for Pharmaceutical.

Transaction
Date
CompanyInsider Code
(see below)
Shares Post Shares Percent
Change
Share
Price
Tran
Value
Post
Value
Percent
Change
2018-02-23 ZTS Trawicki Roman (Executive Vice President) M 23,885 23,885 42.73 1,020,606
2018-02-23 FGEN Neff Thomas B (Chief Executive Officer, Director) M 10,265 3,027,425 0.34 2.35 24,123
2018-02-23 FGEN Neff Thomas B (Chief Executive Officer, Director) S -1,000 3,008,525 -0.03 57.40 -57,400 172,689,335 -0.03
2018-02-23 FGEN Neff Thomas B (Chief Executive Officer, Director) S -6,500 3,009,525 -0.22 56.89 -369,785 171,211,877 -0.22
2018-02-23 FGEN Neff Thomas B (Chief Executive Officer, Director) S -11,400 3,016,025 -0.38 55.90 -637,260 168,595,798 -0.38
2018-02-23 FGEN Neff Thomas B (Chief Executive Officer, Director) S -418 202,780 -0.21 57.11 -23,872 11,580,766 -0.21
2018-02-23 FGEN Neff Thomas B (Chief Executive Officer, Director) S -500 203,198 -0.25 55.79 -27,895 11,336,416 -0.25
2018-02-23 EDGE Leuthner Brian A (President and CEO, Director) S -2,500 460,858 -0.54 15.37 -38,425 7,083,387 -0.54
2018-02-23 ZTS Trawicki Roman (Executive Vice President) S -23,885 0 -100.00 82 -1,958,570
2018-02-22 XNCR Foster Paul A (Chief Medical Officer) M 10,000 12,419 413.39 0.59 5,900
2018-02-22 XNCR Baracchini Edgardo Jr (Chief Business Officer) M 8,069 8,069 0.59 4,761
2018-02-22 DVAX Janssen Robert (Senior Vice President) M 46,875 76,717 157.08
2018-02-22 DVAX Janssen Robert (Senior Vice President) M 8,500 85,217 11.08
2018-02-22 DVAX Janssen Robert (Senior Vice President) M 6,375 91,592 7.48
2018-02-22 DVAX Johnson David Louis (Vice President) M 9,703 17,027 132.48
2018-02-22 DVAX Johnson David Louis (Vice President) M 6,375 23,402 37.44
2018-02-22 DVAX Novack David F (Senior Vice President) M 45,264 57,767 362.03
2018-02-22 DVAX Novack David F (Senior Vice President) M 8,500 66,267 14.71
2018-02-22 DVAX Novack David F (Senior Vice President) M 6,375 77,642 8.95
2018-02-22 DVAX COFFMAN ROBERT (Senior Vice President) M 54,703 61,011 867.20
2018-02-22 DVAX COFFMAN ROBERT (Senior Vice President) M 8,500 69,511 13.93
2018-02-22 DVAX COFFMAN ROBERT (Senior Vice President) M 6,375 75,886 9.17
2018-02-22 DVAX OSTRACH MICHAEL S (Senior Vice President) M 49,805 64,451 340.06
2018-02-22 DVAX OSTRACH MICHAEL S (Senior Vice President) M 8,500 72,951 13.19
2018-02-22 DVAX OSTRACH MICHAEL S (Senior Vice President) M 6,375 79,326 8.74
2018-02-22 DVAX Gray Eddie (CEO and Director, Director) M 75,000 110,573 210.83
2018-02-22 DVAX Gray Eddie (CEO and Director, Director) M 37,000 147,573 33.46
2018-02-22 DVAX Gray Eddie (CEO and Director, Director) M 27,750 175,323 18.80
2018-02-22 FGEN Neff Thomas B (Chief Executive Officer, Director) M 10,265 3,036,060 0.34 2.35 24,123
2018-02-22 PFE CANGIALOSI LORETTA V (Sr. Vice President, Controller) A 4,166 90,055 4.85
2018-02-22 FGEN Neff Thomas B (Chief Executive Officer, Director) S -100 3,017,160 0.00 58.025 -5,802 175,070,709 0.00
2018-02-22 FGEN Neff Thomas B (Chief Executive Officer, Director) S -10,051 3,017,260 -0.33 57.43 -577,229 173,281,242 -0.33
2018-02-22 FGEN Neff Thomas B (Chief Executive Officer, Director) S -8,749 3,027,311 -0.29 56.50 -494,318 171,043,072 -0.29
2018-02-22 FGEN Neff Thomas B (Chief Executive Officer, Director) S -300 203,698 -0.15 57.72 -17,316 11,757,449 -0.15
2018-02-22 FGEN Neff Thomas B (Chief Executive Officer, Director) S -618 203,998 -0.30 56.50 -34,917 11,525,887 -0.30
2018-02-22 EDGE Macdonald R. Loch (Chief Scientific Officer, Director) S -2,500 583,102 -0.43 14.49 -36,225 8,449,148 -0.43
2018-02-22 EDGE Leuthner Brian A (President and CEO, Director) S -2,500 463,358 -0.54 15.47 -38,675 7,168,148 -0.54
2018-02-22 AMAR CHEN STEPHEN T (President, CEO & Chairman, Director, 10% Owner) P 2,500 4,320,741 0.06 0.28 700 1,209,807 0.06
2018-02-22 AMAR CHEN STEPHEN T (President, CEO & Chairman, Director, 10% Owner) P 2,500 4,323,241 0.06 0.27 675 1,167,275 0.06
2018-02-22 CLVS SPICKSCHEN THORLEF (Director) S -4,500 16,618 -21.31 60.00 -270,000 997,080 -27.08
2018-02-22 ZTS Bernal Alejandro (Executive Vice President) S -9,454 6,310 -59.97 81 -765,774 511,110 -149.83
2018-02-22 XNCR Foster Paul A (Chief Medical Officer) S -10,000 2,419 -80.52 26.03 -260,300 62,967 -413.39
2018-02-22 CLSN Martinez Alberto R Jr (Director) P 7,143 20,000 55.56 2.17 15,500 43,400 35.72
2018-02-22 XNCR Baracchini Edgardo Jr (Chief Business Officer) S -8,069 0 -100.00 26.00 -209,794
2018-02-21 HZNP DesJardin Michael A. (EVP, Technical Operations) M 2,181 6,269 53.35
2018-02-21 ZTS Lagano Roxanne (Executive Vice President) M 35,663 49,919 250.16 26 927,238
2018-02-21 ZTS PECK KRISTIN C (Executive Vice President) M 32,000 67,530 90.06 26 832,000
2018-02-21 ARRY VAN LUNSEN GIL J (Director) M 13,500 32,797 69.96 2.46 33,210
2018-02-21 ARRY VAN LUNSEN GIL J (Director) M 8,000 40,797 24.39 3.37 26,960
2018-02-21 ZTS Bernal Alejandro (Executive Vice President) M 32,097 47,861 203.61 26 834,522
A
Grant, award, or other acquisition of securities from the company (such as an option)
K
Equity swaps and similar hedging transactions
P
Purchase of securities on an exchange or from another person
S
Sale of securities on an exchange or to another person
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
M
Exercise or conversion of derivative security received from the company (such as an option)
G
Gift of securities by or to the insider
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)